DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Guo J, Si L, Kong Y et al.
Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification.
J Clin Oncol 2011;
29: 2904-2909
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.